Meanwhile across the pond, Soligenix receives EU orphan drug status for Behçet’s disease treatment
Meanwhile across the pond, Soligenix receives EU orphan drug status for Behçet’s disease treatment Soligenix Inc. (NASDAQ: SNGX) announced that...
Read More →